{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:21:45Z","timestamp":1785450105308,"version":"3.56.0"},"reference-count":140,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>The prevention of sudden cardiac death (SCD) in cardiomyopathies (CM) remains a challenge. The current guidelines still favor the implantation of devices for the primary prevention of SCD only in patients with severely reduced left ventricular ejection fraction (LVEF) and heart failure (HF) symptoms. The implantation of an implantable cardioverter-defibrillator (ICD) is a protective barrier against arrhythmic events in CMs, but the benefit does not outweigh the cost in low risk patients. The identification of high risk patients is the key to an individualized prevention strategy. Cardiac magnetic resonance (CMR) provides reliable and reproducible information about biventricular function and tissue characterization. Furthermore, late gadolinium enhancement (LGE) quantification and pattern of distribution, as well as abnormal T1 mapping and extracellular volume (ECV), representing indices of diffuse fibrosis, can enhance our ability to detect high risk patients. CMR can also complement electro-anatomical mapping (EAM), a technique already applied in the risk evaluation and in the ventricular arrhythmias ablation therapy of CM patients, providing a more accurate assessment of fibrosis and arrhythmic corridors. As a result, CMR provides a new insight into the pathological substrate of CM. CMR may help identify high risk CM patients and, combined with EAM, can provide an integrated evaluation of scar and arrhythmic corridors in the ablative therapy of ventricular arrhythmias.<\/jats:p>","DOI":"10.3390\/diagnostics10080541","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T04:15:31Z","timestamp":1596168931000},"page":"541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Updating the Risk Stratification for Sudden Cardiac Death in Cardiomyopathies: The Evolving Role of Cardiac Magnetic Resonance Imaging. An Approach for the Electrophysiologist"],"prefix":"10.3390","volume":"10","author":[{"given":"Ourania","family":"Kariki","sequence":"first","affiliation":[{"name":"Department of Cardiology, Onassis Cardiac Surgery Centre, 17674 Kallithea, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4861-2404","authenticated-orcid":false,"given":"Christos-Konstantinos","family":"Antoniou","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, National and Kapodistrian University of Athens, Hippokrateion General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Mavrogeni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Onassis Cardiac Surgery Centre, 17674 Kallithea, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos A.","family":"Gatzoulis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, National and Kapodistrian University of Athens, Hippokrateion General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fphys.2020.00092","article-title":"Heart plasticity in response to pressure- and volume-overload: A review of findings in compensated and decompensated phenotypes","volume":"11","author":"Pitoulis","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: A position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur. Heart. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCRESAHA.117.309711","article-title":"Classification, epidemiology, and global burden of cardiomyopathies","volume":"121","author":"McKenna","year":"2017","journal-title":"Circ. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.carpath.2019.06.002","article-title":"Pathobiology of cardiovascular diseases: An update","volume":"42","author":"Buja","year":"2019","journal-title":"Cardiovasc. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.carpath.2016.08.005","article-title":"Anatomopathological changes of the cardiac conduction system in sudden cardiac death, particularly in infants: Advances over the last 25 years","volume":"25","author":"Ottaviani","year":"2016","journal-title":"Cardiovasc.Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.15420\/aer.2018:15:2","article-title":"Sudden cardiac death and arrhythmias","volume":"7","author":"Srinivasan","year":"2018","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.111.025528","article-title":"Sudden death from genetic and acquired cardiomyopathies","volume":"125","author":"McKenna","year":"2012","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e12430","DOI":"10.1111\/anec.12430","article-title":"Arrhythmic risk stratification in heart failure: Time for the next step?","volume":"22","author":"Gatzoulis","year":"2017","journal-title":"Ann. Noninvasive. Electrocardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","article-title":"Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT)","volume":"105","author":"Antz","year":"2002","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1001\/jama.292.23.2874","article-title":"Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials","volume":"292","author":"Desai","year":"2004","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa033088","article-title":"Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy","volume":"350","author":"Kadish","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Thune","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2014AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.08.2162","article-title":"Ejection fraction pros and cons: JACC state-of-the-art review","volume":"72","author":"Marwick","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society","volume":"72","author":"Stevenson","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0195-668X(03)00191-X","article-title":"Out-of-hospital cardiac arrest\u2014The relevance of heart failure. The Maastricht Circulatory Arrest Registry","volume":"24","author":"Gorgels","year":"2003","journal-title":"Eur. Heart, J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","article-title":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: Two-year findings from the Oregon sudden unexpected death study","volume":"47","author":"Stecker","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.hrthm.2015.08.020","article-title":"Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry","volume":"12","author":"Sabbag","year":"2015","journal-title":"Heart Rhythm"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.rcl.2014.11.005","article-title":"Tissue characterization of the myocardium: State of the art characterization by magnetic resonance and computed tomography imaging","volume":"53","author":"Pattanayak","year":"2015","journal-title":"Radiol. Clin."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","article-title":"Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy","volume":"51","author":"Wu","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","article-title":"Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death","volume":"57","author":"Iles","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.hrthm.2014.01.014","article-title":"Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy","volume":"11","author":"PerazzoloMarra","year":"2014","journal-title":"Heart Rhythm"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCHEARTFAILURE.113.000996","article-title":"Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure","volume":"7","author":"Masci","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.hrthm.2015.05.026","article-title":"Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy","volume":"12","author":"Piers","year":"2015","journal-title":"Heart Rhythm"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2016.07.122","article-title":"Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy","volume":"222","author":"Shin","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/hrt.2010.205542","article-title":"Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: Prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy","volume":"97","author":"Lehrke","year":"2011","journal-title":"Heart"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.hrthm.2016.04.013","article-title":"Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients","volume":"13","author":"Zhang","year":"2016","journal-title":"Heart Rhythm"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurjhf\/hft053","article-title":"Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: A meta-analysis","volume":"15","author":"Scott","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tcm.2015.10.003","article-title":"Noninvasive imaging markers associated with sudden cardiac death","volume":"26","author":"Delgado","year":"2016","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Pohost, G.M., and Nayak, K.S. (2006). Handbook of Cardiovascular Magnetic Resonance Imaging, CRC Press. [1st ed.].","DOI":"10.3109\/9780203624371"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kwong, R.Y. (2008). Cardiovascular Magnetic Resonance Imaging, Humana Press Inc.","DOI":"10.1007\/978-1-59745-306-6"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3348\/kjr.2017.18.1.113","article-title":"Myocardial T1 and T2 mapping: Techniques and clinical applications","volume":"18","author":"Kim","year":"2017","journal-title":"Korean J. Radiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000478901","article-title":"T1 and T2 mapping in cardiology: \u201cMapping the obscure object of desire\u201d","volume":"138","author":"Mavrogeni","year":"2017","journal-title":"Cardiology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: A Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3892\/ijmm.2016.2744","article-title":"MRI contrast agents: Classification and application (Review)","volume":"38","author":"Xiao","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0971-3026.209212","article-title":"Gadolinium based contrast agents in current practice: Risks of accumulation and toxicity in patients with normal renal function","volume":"27","author":"Ranga","year":"2017","journal-title":"Indian, J. Radiol. Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3348\/kjr.2018.0356","article-title":"Gadolinium deposition in the brain: Current updates","volume":"20","author":"Choi","year":"2019","journal-title":"Korean, J. Radiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: Summary of evidence and recommendations","volume":"16","author":"Gulani","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of myocardial fibrosis with cardiovascular magnetic resonance","volume":"57","author":"Mewton","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 mapping and Extracellular Volume (ECV) in clinical practice: A comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2459\/JCM.0000000000000275","article-title":"Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy","volume":"16","author":"Barison","year":"2015","journal-title":"J. Cardiovasc. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ehjci\/jeu183","article-title":"T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: Quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy","volume":"16","author":"Buss","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcmg.2015.11.002","article-title":"T1 mapping by CMR imaging: From histological validation to clinical implication","volume":"9","author":"Kammerlander","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcmg.2015.11.005","article-title":"T1 mapping: Basic techniques and clinical applications","volume":"9","author":"Taylor","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1161\/CIRCULATIONAHA.105.549659","article-title":"Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy","volume":"112","author":"Nazarian","year":"2005","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jcmg.2012.09.012","article-title":"Prognostic role of CMR in patients presenting with ventricular arrhythmias","volume":"6","author":"Dawson","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijcard.2014.08.132","article-title":"Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy","volume":"177","author":"Demirel","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcmg.2011.08.021","article-title":"Delayed-enhanced MR scar imaging and intraprocedural registration into an electroanatomical mapping system in post-infarction patients","volume":"5","author":"Gupta","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCEP.111.961946","article-title":"Integration of 3D electroanatomic maps and magnetic resonance scar characterization into the navigation system to guide ventricular tachycardia ablation","volume":"4","author":"Andreu","year":"2011","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jcmg.2018.03.006","article-title":"The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: A review and meta-analysis","volume":"11","author":"Becker","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: Systematic review and meta-analysis","volume":"5","author":"Anguera","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Halliday, B.P., Baksi, A.J., Gulati, A., Ali, A., Newsome, S., Izgi, C., Arzanauskaite, M., Lota, A., Tayal, U., and Vassiliou, V.S. (2019). Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC Cardiovasc. Imaging, 1645\u20131655.","DOI":"10.1016\/j.jcmg.2018.07.015"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Mueller, K.A., Heck, C., Heinzmann, D., Schwille, J., Klingel, K., Kandolf, R., Kramer, U., Gramlich, M., Geisler, T., and Gawaz, M.P. (2016). Comparison of ventricular inducibility with late gadolinium enhancement and myocardial inflammation in endomyocardial biopsy in patients with dilated cardiomyopathy. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167616"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0284185115580840","article-title":"Relationship of postcontrast myocardial T1 value and delayed enhancement to reduced cardiac function and serious arrhythmia in dilated cardiomyopathy with left ventricular ejection fraction less than 35","volume":"57","author":"Tachi","year":"2016","journal-title":"Acta Radiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","article-title":"T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure","volume":"9","author":"Puntmann","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10554-015-0595-0","article-title":"Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: Comparison with healthy control subjects","volume":"31","author":"Hong","year":"2015","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jcmg.2017.04.006","article-title":"Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy","volume":"11","author":"Nakamori","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ehjci\/jeu181","article-title":"Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy","volume":"16","author":"Buss","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12968-016-0255-0","article-title":"Left ventricular long axis strain: A new prognosticator in non-ischemic dilated cardiomyopathy?","volume":"18","author":"Riffel","year":"2016","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12968-018-0466-7","article-title":"Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction","volume":"20","author":"Pi","year":"2018","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198606000-00014","article-title":"Resection of scarred papillary muscles improves outcome after surgery for ventricular tachycardia","volume":"203","author":"Kron","year":"1986","journal-title":"Ann. Surg."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/01.CIR.60.7.1430","article-title":"Endocardial excision: A new surgical technique for the treatment of recurrent ventricular tachycardia","volume":"60","author":"Josephson","year":"1979","journal-title":"Circulation"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0003-4975(10)63001-9","article-title":"Extended endocardial resection for the treatment of ventricular tachycardia and ventricular fibrillation","volume":"34","author":"Moran","year":"1982","journal-title":"Ann. Thorac. Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/europace\/euz163","article-title":"Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: An European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)","volume":"21","author":"Kalarus","year":"2019","journal-title":"Europace"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/ehjci\/jes302","article-title":"Prediction of ventricular arrhythmias using cardiovascular magnetic resonance","volume":"14","author":"Mavrogeni","year":"2013","journal-title":"Eur. Heart, J. Cardiovasc. Imaging"},{"key":"ref_73","first-page":"403","article-title":"Ventricular scars and ventricular tachycardia","volume":"120","author":"Stevenson","year":"2009","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e006569","DOI":"10.1161\/CIRCEP.118.006569","article-title":"Characteristics of scar-related ventricular tachycardia circuits using ultra-high-density mapping: A multi-center study","volume":"11","author":"Martin","year":"2018","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.CIR.68.3.518","article-title":"Recurrent sustained ventricular tachycardia: Structure and ultrastructure of subendocardial regions in which tachycardia originates","volume":"68","author":"Fenoglio","year":"1983","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.106.653568","article-title":"Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction","volume":"115","author":"Schmidt","year":"2007","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e006105","DOI":"10.1161\/CIRCIMAGING.116.006105","article-title":"Cardiovascular magnetic resonance to predict appropriate implantable cardioverter defibrillator therapy in ischemic and nonischemic cardiomyopathy patients using late gadolinium enhancement border zone: Comparison of four analysis methods","volume":"10","author":"Jablonowski","year":"2017","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCIMAGING.108.826529","article-title":"Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator","volume":"2","author":"Roes","year":"2009","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"A1454","DOI":"10.1016\/S0735-1097(18)31995-8","article-title":"Diffuse myocardial fibrosis measured by extracellular volume associates with incident ventricular arrhythmia in implantable cardioverter defibrillator recipients more than focal fibrosis","volume":"71","author":"Olausson","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.hrthm.2014.12.020","article-title":"Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators","volume":"12","author":"Chen","year":"2015","journal-title":"Heart Rhythm"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/ehz260","article-title":"Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study","volume":"40","author":"Gatzoulis","year":"2019","journal-title":"Eur. Heart, J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hjc.2017.03.002","article-title":"Ventricular arrhythmogenic potential assessment in an asymptomatic ischemic cardiomyopathy patient with a normal ejection fraction","volume":"58","author":"Gatzoulis","year":"2017","journal-title":"Hell. J. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1093\/eurheartj\/ehz410","article-title":"Risk stratification for sudden cardiac death: Show me the money!","volume":"40","author":"Velasquez","year":"2019","journal-title":"Eur. Heart, J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amjcard.2015.05.047","article-title":"Independent assessment of the european society of cardiology sudden death risk model for hypertrophic cardiomyopathy","volume":"116","author":"Maron","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCEP.114.002553","article-title":"Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"8","author":"Vriesendorp","year":"2015","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"Jichi","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2017.10.033","article-title":"Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy","volume":"254","author":"Gatzoulis","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_91","first-page":"e194534","article-title":"Mortality among referral patients with hypertrophic cardiomyopathy vs the general European population","volume":"27","author":"Lorenzini","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","article-title":"Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: Systematic review and meta-analysis","volume":"5","author":"Schinkel","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jcmg.2016.01.032","article-title":"LGE means better selection of HCM patients for primary prevention implantable defibrillators","volume":"9","author":"Maron","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1136\/heartjnl-2013-305471","article-title":"Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy","volume":"100","author":"Ismail","year":"2014","journal-title":"Heart"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2007.11.071","article-title":"Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance","volume":"51","author":"Adabag","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/eurheartj\/ehp152","article-title":"Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy","volume":"30","author":"Leonardi","year":"2009","journal-title":"Eur. Heart J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","article-title":"Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy","volume":"56","author":"Bruder","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.amjcard.2019.07.023","article-title":"Prognostic role of late gadolinium enhancement in patients with hypertrophic cardiomyopathy and low-to-intermediate sudden cardiac death risk score","volume":"124","author":"Todiere","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jce.12948","article-title":"Diffuse ventricular fibrosis on cardiac magnetic resonance imaging associates with ventricular tachycardia in patients with hypertrophic cardiomyopathy","volume":"27","author":"McLELLAN","year":"2016","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00380-012-0300-3","article-title":"High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy","volume":"28","author":"Hen","year":"2013","journal-title":"Heart Vessel."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1007\/s00330-017-4869-x","article-title":"Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR","volume":"27","author":"Avanesov","year":"2017","journal-title":"Eur. Radiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2018.10.067","article-title":"Cardiovascular magnetic resonance imaging pattern in patients with autoimmune rheumatic diseases and ventricular tachycardia with preserved ejection fraction","volume":"284","author":"Mavrogeni","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1381612824666180111111124","article-title":"Torsades de pointes in patients with polymyalgia rheumatica","volume":"24","author":"Lazzerini","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_107","first-page":"1717","article-title":"Systemic inflammation and arrhythmic risk: Lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/rheumatology\/kep134","article-title":"Cardiovascular autonomic function assessed by autonomic function tests and serum autonomic neuropeptides in Egyptian children and adolescents with rheumatic diseases","volume":"48","author":"Mostafa","year":"2009","journal-title":"Rheumatology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00431-018-3122-1","article-title":"Cardiac autonomic function in children with type 1 diabetes","volume":"177","author":"Metwalley","year":"2018","journal-title":"Eur. J. Pediatr."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.111.049882","article-title":"Inducible ventricular tachycardia due to dermatomyositis-related cardiomyopathy in the era of implantable cardioverter-defibrillator therapy","volume":"125","author":"Dilaveris","year":"2012","journal-title":"Circulation"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pcad.2007.10.003","article-title":"Sudden cardiac death in infiltrative cardiomyopathies: Sarcoidosis, scleroderma, amyloidosis, hemachromatosis","volume":"51","author":"Lubitz","year":"2008","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Mavrogeni, S., Gargani, L., Pepe, A., Monti, L., Markousis-Mavrogenis, G., De Santis, M., Marchi, D., Koutsogeorgopoulou, L., Karabela, G., and Stavropoulos, E. (2019). Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: The Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS). Rheumatology, kez494.","DOI":"10.1093\/rheumatology\/kez494"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: Results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study","volume":"129","author":"Dinov","year":"2014","journal-title":"Circulation"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e007249","DOI":"10.1161\/CIRCEP.119.007249","article-title":"Comparison of the ventricular tachycardia circuit between patients with ischemic and nonischemic cardiomyopathies: Detailed characterization by entrainment","volume":"12","author":"Shirai","year":"2019","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4065\/84.3.289","article-title":"Ventricular tachycardia and sudden cardiac death","volume":"84","author":"Koplan","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"ref_116","first-page":"42","article-title":"Beh\u00e7et\u2019s disease cardiomyopathy: The role of magnetic resonance imaging and electroanatomical mapping in diagnosis and treatment","volume":"1","author":"Antonopoulos","year":"2017","journal-title":"Case report. Curr. Cardiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12410-019-9481-9","article-title":"Advances in real-time MRI-guided electrophysiology. Version 2","volume":"12","author":"Mukherjee","year":"2019","journal-title":"Curr. Cardiovasc. Imaging Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/eurheartj\/ehq345","article-title":"Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: Real-time image integration and reversed registration","volume":"32","author":"Wijnmaalen","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCEP.113.000264","article-title":"Three-dimensional architecture of scar and conducting channels based on high resolution ce-CMR: Insights for ventricular tachycardia ablation","volume":"6","author":"Berruezo","year":"2013","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.hrthm.2017.05.018","article-title":"Cardiac magnetic resonance-aided scar dechanneling: Influence on acute and long-term outcomes","volume":"14","author":"Andreu","year":"2017","journal-title":"Heart Rhythm"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacep.2016.07.005","article-title":"Development, preclinical validation, and clinical translation of a cardiac magnetic resonance\u2014Electrophysiology system with active catheter tracking for ablation of cardiac arrhythmia","volume":"3","author":"Chubb","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/europace\/euz165","article-title":"Evaluation of a real-time magnetic resonance imaging-guided electrophysiology system for structural and electrophysiological ventricular tachycardia substrate assessment","volume":"21","author":"Mukherjee","year":"2019","journal-title":"Europace"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"85","DOI":"10.15420\/aer.2017:1:2","article-title":"Cardiac electrophysiology under MRI guidance: An Emerging technology","volume":"6","author":"Chubb","year":"2017","journal-title":"Arrhythmia Electrophysiol. Rev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/CIRCEP.112.973164","article-title":"Identification and acute targeting of gaps in atrial ablation lesion sets using a real-time magnetic resonance imaging system","volume":"5","author":"Ranjan","year":"2012","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/CIRCEP.113.001163","article-title":"Intrinsic contrast for characterization of acute radiofrequency ablation lesions","volume":"7","author":"Celik","year":"2014","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.hrthm.2006.10.019","article-title":"Characterization of acute and subacute radiofrequency ablation lesions with nonenhanced magnetic resonance imaging","volume":"4","author":"Dickfeld","year":"2007","journal-title":"Heart Rhythm"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/CIRCEP.111.966523","article-title":"Acute pulmonary vein isolation is achieved by a combination of reversible and irreversible atrial injury after catheter ablation: Evidence from magnetic resonance imaging","volume":"5","author":"Arujuna","year":"2012","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/eurheartj\/eht560","article-title":"Cardiac magnetic resonance and electroanatomical mapping of acute and chronic atrial ablation injury: A histological validation study","volume":"35","author":"Harrison","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.hrthm.2010.10.032","article-title":"Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla","volume":"8","author":"Vergara","year":"2011","journal-title":"Heart Rhythm"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacep.2018.11.001","article-title":"Ablation lesion characterization in scarred substrate assessed using cardiac magnetic resonance","volume":"5","author":"Tao","year":"2019","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12968-017-0323-0","article-title":"Feasibility of real-time MR thermal dose mapping for predicting radiofrequency ablation outcome in the myocardium in vivo","volume":"19","author":"Toupin","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"259","DOI":"10.21037\/qims.2017.03.05","article-title":"Evaluation of MR thermometry with proton resonance frequency method at 7T","volume":"7","author":"Wang","year":"2017","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCEP.113.000216","article-title":"Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: Reappraisal of the role of programmed ventricular stimulation","volume":"6","author":"Gatzoulis","year":"2013","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.echo.2012.02.004","article-title":"Risk assessment of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy by strain echocardiography","volume":"25","author":"Haugaa","year":"2012","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jcmg.2013.03.005","article-title":"Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction","volume":"6","author":"Haugaa","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e003019","DOI":"10.1161\/CIRCIMAGING.115.003019","article-title":"Novel imaging approaches for predicting arrhythmic risk","volume":"8","author":"Travin","year":"2015","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cjca.2019.11.009","article-title":"A novel risk stratification score for sudden cardiac death prediction in middle-aged, nonischemic dilated cardiomyopathy patients: The ESTIMATED score","volume":"36","author":"Li","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e12420","DOI":"10.1111\/anec.12420","article-title":"Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial","volume":"22","author":"Selvanayagam","year":"2017","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"ref_139","first-page":"S1109-9666(20)30075-0","article-title":"Arrhythmic risk stratification in nonischemic dilated cardiomyopathy: The ReCONSIDER study design\u2014A two-step, multifactorial, electrophysiology-inclusive approach","volume":"21","author":"Gatzoulis","year":"2020","journal-title":"Hell. J. Cardiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijcard.2017.12.019","article-title":"Was a mistake made when programmed electrical stimulation was eliminated as a sudden death risk marker in hypertrophic cardiomyopathy?","volume":"254","author":"Monfredi","year":"2018","journal-title":"Int. J. Cardiol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/8\/541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:53:09Z","timestamp":1760176389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/8\/541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":140,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["diagnostics10080541"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics10080541","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]}}}